Main
>
NEUROLOGY.
>
Multiple Sclerosis
>
Treatment
>
AlemtuzuMAb (Anti CD52 MAb)
>
Co.: USA. G. (Phase III/Patent)
>
Company
This data is not available for free
Company's products
This section has no products